Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery

Haobo Han,1,2 Wenqi Chen,2 Jiebing Yang,2 Xiao Liang,2 Yudi Wang,2 Quanshun Li,2 Yan Yang,2 Kun Li1 1School of Nursing, 2Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun, People’s Republic of China Intr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Han H, Chen W, Yang J, Liang X, Wang Y, Li Q, Yang Y, Li K
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/bc47485eb5ca44b49f7046509e308e5e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bc47485eb5ca44b49f7046509e308e5e
record_format dspace
spelling oai:doaj.org-article:bc47485eb5ca44b49f7046509e308e5e2021-12-02T02:26:26ZInhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery1178-2013https://doaj.org/article/bc47485eb5ca44b49f7046509e308e5e2018-03-01T00:00:00Zhttps://www.dovepress.com/inhibition-of-cell-proliferation-and-migration-through-nucleobase-modi-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Haobo Han,1,2 Wenqi Chen,2 Jiebing Yang,2 Xiao Liang,2 Yudi Wang,2 Quanshun Li,2 Yan Yang,2 Kun Li1 1School of Nursing, 2Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun, People’s Republic of China Introduction: The nucleobase 2-amino-6-chloropurine-modified polyamidoamine (AP-PAMAM) was used as a carrier for p53 gene delivery to achieve the antitumor effects. Methods and materials: The condensation of p53 plasmid was studied through gel retardation assay, and the transfection efficiency was evaluated through the transfection assay of pEGFP-N3 and pGL-3 plasmids. Using human cervical carcinoma cell line HeLa as a model, the inhibition of cell proliferation and migration was studied through flow cytometry, wound healing and Transwell migration assays, respectively. The p53 expression level was detected through quantitative polymerase chain reaction and Western blotting analyses. Results: The carrier could condense p53 plasmid into stable nanoparticles at N/P ratios of 2.0, and higher transfection efficiency than polyamidoamine (PAMAM) could be obtained at all the N/P ratios studied. AP-PAMAM-mediated p53 delivery could achieve stronger antiproliferative effect than PAMAM/p53. The antiproliferative effect was identified to be triggered by the induction of cell apoptosis (apoptotic ratio of 26.17%) and cell cycle arrest at S phase. Additionally, AP-PAMAM/p53 transfection has been found to suppress the cell migration and invasion of cancer cells. Finally, the enhanced p53 expression level could be detected after p53 transfection at mRNA and protein levels. Conclusion: The PAMAM derivative-mediated p53 delivery could be a promising strategy for achieving tumor gene therapy. Keywords: nucleobase, polyamidoamine, p53 delivery, cell proliferation, cell migrationHan HChen WYang JLiang XWang YLi QYang YLi KDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 1297-1311 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Han H
Chen W
Yang J
Liang X
Wang Y
Li Q
Yang Y
Li K
Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery
description Haobo Han,1,2 Wenqi Chen,2 Jiebing Yang,2 Xiao Liang,2 Yudi Wang,2 Quanshun Li,2 Yan Yang,2 Kun Li1 1School of Nursing, 2Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun, People’s Republic of China Introduction: The nucleobase 2-amino-6-chloropurine-modified polyamidoamine (AP-PAMAM) was used as a carrier for p53 gene delivery to achieve the antitumor effects. Methods and materials: The condensation of p53 plasmid was studied through gel retardation assay, and the transfection efficiency was evaluated through the transfection assay of pEGFP-N3 and pGL-3 plasmids. Using human cervical carcinoma cell line HeLa as a model, the inhibition of cell proliferation and migration was studied through flow cytometry, wound healing and Transwell migration assays, respectively. The p53 expression level was detected through quantitative polymerase chain reaction and Western blotting analyses. Results: The carrier could condense p53 plasmid into stable nanoparticles at N/P ratios of 2.0, and higher transfection efficiency than polyamidoamine (PAMAM) could be obtained at all the N/P ratios studied. AP-PAMAM-mediated p53 delivery could achieve stronger antiproliferative effect than PAMAM/p53. The antiproliferative effect was identified to be triggered by the induction of cell apoptosis (apoptotic ratio of 26.17%) and cell cycle arrest at S phase. Additionally, AP-PAMAM/p53 transfection has been found to suppress the cell migration and invasion of cancer cells. Finally, the enhanced p53 expression level could be detected after p53 transfection at mRNA and protein levels. Conclusion: The PAMAM derivative-mediated p53 delivery could be a promising strategy for achieving tumor gene therapy. Keywords: nucleobase, polyamidoamine, p53 delivery, cell proliferation, cell migration
format article
author Han H
Chen W
Yang J
Liang X
Wang Y
Li Q
Yang Y
Li K
author_facet Han H
Chen W
Yang J
Liang X
Wang Y
Li Q
Yang Y
Li K
author_sort Han H
title Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery
title_short Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery
title_full Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery
title_fullStr Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery
title_full_unstemmed Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery
title_sort inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/bc47485eb5ca44b49f7046509e308e5e
work_keys_str_mv AT hanh inhibitionofcellproliferationandmigrationthroughnucleobasemodifiedpolyamidoaminemediatedp53delivery
AT chenw inhibitionofcellproliferationandmigrationthroughnucleobasemodifiedpolyamidoaminemediatedp53delivery
AT yangj inhibitionofcellproliferationandmigrationthroughnucleobasemodifiedpolyamidoaminemediatedp53delivery
AT liangx inhibitionofcellproliferationandmigrationthroughnucleobasemodifiedpolyamidoaminemediatedp53delivery
AT wangy inhibitionofcellproliferationandmigrationthroughnucleobasemodifiedpolyamidoaminemediatedp53delivery
AT liq inhibitionofcellproliferationandmigrationthroughnucleobasemodifiedpolyamidoaminemediatedp53delivery
AT yangy inhibitionofcellproliferationandmigrationthroughnucleobasemodifiedpolyamidoaminemediatedp53delivery
AT lik inhibitionofcellproliferationandmigrationthroughnucleobasemodifiedpolyamidoaminemediatedp53delivery
_version_ 1718402491646738432